Document is current
Any future updates will be listed below
-
Authors
Greeley, Krista M. https://orcid.org/0009-0007-6076-8563
Rash, Joshua https://orcid.org/0000-0003-0927-0712
Tulk, Joshua https://orcid.org/0000-0001-9908-263X
Savard, Josée https://orcid.org/0000-0002-8052-1046
Seal, Melanie
Urquhart, Robin https://orcid.org/0000-0001-8864-5716
Thoms, John
Laing, Kara
Fawcett, Emily https://orcid.org/0000-0002-4734-974X
Garland, Sheila N. https://orcid.org/0000-0002-6119-318X
-
Funding
Funding for this research was provided by:
Canadian Cancer Society (707939, 707146)
Canadian Institutes of Health Research (PJT 162428)
- License Information
-
More Information
Article History
Received: 13 September 2024
Accepted: 20 April 2025
First Online: 28 April 2025
Declarations
:
: This is a secondary analysis of a randomized controlled trial (clinicaltrials.gov identifier: NCT04026048). Ethical approval was obtained by the Memorial University Health Research Ethics Authority (#20200427). Informed consent was obtained before participation. This trial followed principles in accordance with the Declaration of Helsinki.
: The authors declare no competing interests.
